Clinigen Group plc (CLIN) Ordinary 0.1p
Share news, reports & tips
6 April 2021 13:27
(Sharecast News) - Touchstone Exploration: Canaccord downgrades to speculative buy with a target price of 140p.
6 April 2021 08:37
(Sharecast News) - Pharmaceutical products and services company Clinigen Group announced on Tuesday that it will be providing access to 'Erwinase', or L-asparaginase Erwinia chrysanthemi, in the UK...
5 March 2021 13:07
(Sharecast News) - Aggreko: Peel Hunt upgrades to hold with a target price of 880p.
23 February 2021 13:39
(Sharecast News) - Clinigen: Liberum reiterates buy with a target price of 1,050p.
1 February 2021 13:44
(Sharecast News) - Polymetal International: Berenberg reiterates buy with a target price of 2,310p.
14 January 2021 09:47
(Sharecast News) - Pharmaceuticals products and services company Clinigen Group updated the market on its first half on Thursday, reporting that Covid-19 had continued to impact its business as global...
26 November 2020 09:18
(Sharecast News) - Pharmaceutical and services company Clinigen said on Thursday that trading had been in-line with market expectations despite the ongoing impact of the Covid-19 pandemic.
23 November 2020 13:28
(Sharecast News) - DWF Group: Liberum initiates at hold with a target price of 90p.
10 November 2020 13:17
(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.
23 July 2020 14:25
(Sharecast News) - Stagecoach Group: Peel Hunt upgrades to buy with a target price of 70.0p.
14 July 2020 09:07
(Sharecast News) - Pharmaceutical group Clinigen warned full-year profit growth would be at the lower end of guidance as a result of the Covid-19 pandemic and the launch of a low-cost competitor to its...
13 July 2020 16:29
(Sharecast News) - Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.